Oslo Cancer Cluster´s vision is to improve the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
In our every-day work the Management Team of the cluster does not engage directly with patient care or cancer patients. If you have any patient-related questions, please contact your GP or our member the Norwegian Cancer Society (Kreftforeningen) – the Norwegian cancer patient organization. However, several of the issues we work for in the Oslo Cancer Cluster are directly patient-related:
National Cancer Drug Fund
Oslo Cancer Cluster would like to get the Norwegian Government to implement a National Cancer Drug Fund. The fund is meant as as temporary financing mechanism in order to both secure and speed up access to new cancer drugs. The Norwegian Cancer Society and the Association of the Pharmaceutical Industry in Norway (LMI) also stands behind this suggestion.
Oslo Cancer Cluster would like to implement a Governmental system that gives all cancer patients the right to get assessed for the inclusion to a clinical trial, as we believe this is good patient care and a right every cancer patient should have. We also work hard to increase the number of oncology clinical trials in Norway, both investigator driven and industry driven. You may read more about our work within Clinical Trials here.
Do you have questions regarding clinical trials or would like to join one?
Please contact either the Clinical Cancer Research Unit at Oslo University Hospital and/or the Clinical Trial Unit at Haukeland University Hospital. These are the two places in Norway conducting clinical trials within oncology.